Cambridge, United Kingdom
Camena Bioscience, headquartered in the United Kingdom and founded in 2016, is an emerging player in the Biotechnology and Health Care industries. The company lives by its slogan, "Unlocking access to genes with unparalleled accuracy," positioning itself as a pivotal enabler for synthetic biologists.
Camena focuses on producing complex gene sequences, a capability crucial for various sectors including pharmaceuticals, agriculture, and diagnostics. These gene sequences are typically difficult to create, offering a distinct advantage to researchers engaged in the synthetic biology revolution. While the company operates out of Cambridge, UK, it boasts a global clientele.
Their most recent financial milestone was securing a £7.90M Series A investment from Mercia Asset Management as of 03 July 2023. This significant investment underscores the market's confidence in Camena's innovative technology and growth potential.
